Thomas Nusbickel's most recent trade in CorMedix Inc was a trade of 100,000 Stock Option (Right to Buy Common Stock) done . Disclosure was reported to the exchange on Feb. 18, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CorMedix Inc | Thomas Nusbickel | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Thomas Nusbickel | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 260,000 | 260,000 | - | - | Stock Option (Right to Buy Common Stock) | |
| CorMedix Inc | Thomas Nusbickel | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 7,500 | 7,500 | - | - | Stock Option (Right to Buy Common Stock) |